SEMA4D and neoplasm: However, this seems to differ between tumor type with a tumor-suppressor effect mainly noted in ER-positive breast cancer and melanoma, were binding of Sema4D to PlexinB1 leads to a decrease in cMET phosphorylation [45,46,47].